magnifying glass
logo for Opiant Pharmaceuticals

Opiant Pharmaceuticals

Get Full Access

Description

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. NIDA, a division of the National Insti... Read More

Headquarters

Headquarters:

233 Wilshire Blvd, Ste 280 Ste 500, Santa Monica, California, 90401, United States
Phone

Phone:

(310) 598-5410
Employees

Employees:

<25
Revenue

Revenue:

$40 Million
Stock Symbol

Stock Symbol:

OPNT
Opiant Pharmaceuticals's Social Media
SIC Code 28,283
NAICS Code 32541,325
Ticker NASDAQ: OPNT
Popular Searches:

Opiant Pharmaceuticals Inc

Opiant Pharmaceuticals , Inc.

Opiant Pharmaceuticals, Inc.

OPIANT PHARMACEUTICALS

Opiant

Top Competitors of Opiant Pharmaceuticals

Employess
96
revenue
$19 Million

1

Employess
25
revenue
$5 Million

2

Employess
<25
revenue
<$5 Million

3

Employess
193
revenue
$77 Million

4

Employess
79
revenue
$16 Million

5

Employess
164
revenue
$251 Million

6

Opiant Pharmaceuticals's Org Chart

Roger Crystal
Roger Crystal

President, Chief Executive Officer

PhonePhoneEmailEmail
David O'Toole
David O'Toole

Chief Financial Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Opiant Pharmaceuticals's Tech Stack

Adobe Activation

By

Adobe

Google Cloud Platform

By

Google

Office 365

By

Microsoft

Drupal

By

Drupal

Google Universal Analytics

By

Google

Google Font API

By

Google
See more technologies

Opiant Pharmaceuticals News & Media

Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SANTA MONICA, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced the Compensation Committee of the Company’s Board of Directors has approved the grant of restricted stock units (“RSU”) covering an aggregate of 31,500 shares of common stock to six hired employees, pursuant to the Company’s 2021 Inducement Equity Incentive Plan (

Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three and nine months ended September 30, 2021, and provided a corporate update. Recent highlights include:

Moon Rabbit Named Agency of Record by Opiant Pharmaceuticals

Creative agency to support commercialization of opioid overdose treatment (PRWeb October 25, 2021) Read the full story at https://www.prweb.com/releases/moon_rabbit_named_agency_of_record_by_opiant_pharmaceuticals/prweb18279378.htm
Subscribe to "Opiant Pharmaceuticals" News

Frequently Asked Questions regarding Opiant Pharmaceuticals

Where are Opiant Pharmaceuticals’s headquarters?

Opiant Pharmaceuticals’s headquarters are in 233 Wilshire Blvd, Ste 280 Ste 500, Santa Monica, California, 90401, United States

What is Opiant Pharmaceuticals’s phone number?

Opiant Pharmaceuticals’s phone number is (310) 598-5410

What is Opiant Pharmaceuticals’s stock symbol?

Opiant Pharmaceuticals’s stock symbol is OPNT

What is Opiant Pharmaceuticals’s official website?

Opiant Pharmaceuticals’s official website is //www.opiant.com

What is Opiant Pharmaceuticals’s Revenue?

Opiant Pharmaceuticals’s revenue is $40 Million

What is Opiant Pharmaceuticals’s SIC code?

Opiant Pharmaceuticals’s SIC: 28,283

What is Opiant Pharmaceuticals’s NAICS code?

Opiant Pharmaceuticals’s NAICS: 32541,325

How many employees are working in Opiant Pharmaceuticals?

Opiant Pharmaceuticals has <25 employees

What is Opiant Pharmaceuticals’s industry?

Opiant Pharmaceuticals is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

Who are Opiant Pharmaceuticals’s main competitors?

Opiant Pharmaceuticals's main competitors are: Embera NeuroTherapeutics, Pantarhei Bioscience, MediQuest Therapeutics, Heron Therapeutics

What is Opiant Pharmaceuticals's tech stack?

The technologies that are used by Opiant Pharmaceuticals are: Adobe Activation, Google Cloud Platform, Office 365, Drupal

Who is Opiant Pharmaceuticals's CEO?

Opiant Pharmaceuticals's CEO is Roger Crystal

Who is Opiant Pharmaceuticals's CFO?

Opiant Pharmaceuticals's CFO is David O'Toole

See more information about Opiant Pharmaceuticals

Browse ZoomInfo’s Directories